Polymorphisms in TNF and HSP-70 show a significant association with gastric cancer and duodenal ulcer

International Journal of Cancer

Volumn 126, Issue 8, 2010, Pages 1861-1868

  Partida Rodríguez, Oswaldo ^a   Torres, Javier ^a   Flores Luna, Lourdes ^b   Camorlinga, Margarita ^a   Nieves Ramírez, Miriam ^a   Lazcano, Eduardo ^b   Perez Rodríguez, Martha ^a  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

Duodenal ulcer; Gastric cancer; Genetic polymorphism; Heat shock protein 70; Tumour necrosis factor

Indexed keywords

CYSTEINE; DNA; GLYCINE; HEAT SHOCK PROTEIN 70; LYMPHOTOXIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; CANCER GENETICS; CANCER STAGING; CONTROLLED STUDY; DISEASE MARKER; DUODENUM CANCER; DUODENUM ULCER; FEMALE; GASTRITIS; GENE DOSAGE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; INFLAMMATION; INTESTINE METAPLASIA; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MEXICO; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HELICOBACTER INFECTION; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; PRECANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; STOMACH TUMOR;

ADULT; DUODENAL ULCER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HELICOBACTER INFECTIONS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECANCEROUS CONDITIONS; RISK FACTORS; STOMACH NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77949897859     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24773     Document Type: Article

References (62)

1. Crabtree JE, Shalicross TM, Heatley RV, Wyatt JI. Mucosal tumour necrosis factor α and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991; 32:147-177
2. Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytgat GN. Mucosal tumor necrosis factor α, interleukin 1β, and interleukin-8 production in. patients with Helicobacter pyloriinfection. Scand J Gastroenterol 1994; 29: 425-429 (Pubitemid 24144511)
3. Yamaoka Y, Kita M, Kodama T, Sawai N, Tanahashi T, Kashima K, Imanishi J. Chemokines in the gastric mucosa in Helicobacter pylori infection. Gut 1998; 42: 609-617 (Pubitemid 28261044)
4. Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest 2007; 117: 60-69
5. Correa P.c Human Gastric Carcinogenesis: A multistep and multifactorial process First American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992; 52:6735-6740
6. Khulusi S, Badve S, Patel P, Lloyd R, Marrero JM, Finlayson C, Mendall MA, Northfield TC. Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration. Gastroenterology 1996; 110: 452-458 (Pubitemid 26043878)
7. Zambon CF, Basso D, Navaglia F, Belluco C, Falda A, Fogar P, Greco E, Gallo N, Rugge M, Di Mario F, Plebani M. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine 2005; 29:141-152 (Pubitemid 40126232)
8. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, Stanford JL, Mayne ST, Goedert J, Blot WJ, Fraumeni JF Jr, Chow WH. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003; 124:1193-1201 (Pubitemid 36531795)
9. Camargo MC, Mera R, Correa P, Peek RM Jr, Fontham. ET, Goodman KJ, Piazuelo MB, Sicinschi L, Zabaleta J, Schneider BG. Interleukin-1β and Interleukin-1 Receptor Antagonist gene polymorphisms and gastric cancer: A meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 1674-1687 (Pubitemid 44497104)
10. Azuma T, Ito S, Sato F, Yamazaki Y, Miyaji H, Ito Y, Suto H, Kuriyama M, Kato T, Kohii Y. The role of the HLADQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection. Cancer 1998; 82:1013-1018 (Pubitemid 28138079)
11. Shiina T, Inoko H, Kulski JK. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 2004; 64:631-649 (Pubitemid 39628044)
12. Sargent CA, Dunham. I, Trowsdale J, Campbell RD, Human Major Histocompatibility complex contains genes for the major heat shock protein HSP70. Proc Natl Acad Sci USA 1989; 86:1968-1972 (Pubitemid 19087049)
13. Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumor necrosis factor alpha (TNF-α) gene detectable by NcoI restriction of PCR product. Human Mol Genet 1992; 1:353.
14. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94:3195-3199
15. Messer G, Spengler U, Jung MC, Honold G, Blömer K, Pape GR, Riethmüller G, Weiss EH, Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and reduced level of TNF-β production. J Exp Med 1991; 173:209-219
16. Stüber F, Petersen M, Bokelmann F, Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-a concentrations and outcome of patients with severe sepsis. Crit Care Med 1996; 24: 381-384
17. Milner CM, Campbell RD. Structure and expression of the three MHC-linked HSP70 genes. Immunogenetics 1990; 32: 242-251
18. Vargas-Alarcón G, Londoño JD, Hernández-Pacheco G, Gamboa R, Castillo E, Pacheco-Tena C, Cardiel MH, Granados J, Burgos-Vargas R. Heat shock protein 70 gene polymorphism in Mexican patients with spondyloarthropathies. Ann Rheum Dis 2002; 61:48-51.
19. Jalbout M, Bouaouina N, Gargouri J, Corbex M, Ben AS, Chouchane L. Polymorphism of the stress protein HSP70-2 gene is associated with the susceptibility to the nasopharyngeal carcinoma. Cancer Lett 2003: 193:75-81.
20. Rugge M, Correa P, Dixon MF, Fiocca R, Hattori T, Lechago J, Leandro G, Price AB, Sipponen P, Solcia E, Watanabe H, Genta RM. Gastric mucosal, atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002; 16:1249-1259
21. Genta RM. Chap 8. Inflammatory disorders of the stomach. In: Odze R, Goldblum J, Crawford JM eds. Surgical Pathology of the GI tract, liver, biliary tract and pancreas. China: Saunders. 2004, 169 P.
22. Miller SA, Dykes KK, Plesky HF. A simple salting out procedure for extracting DNA from human nucleated cell. Nucleic Acid Res 1988; 16:1215.
23. Camorlinga M., Torres J, Perez-Perez G, Leal-Herrera Y, Gonzalez-Ortiz B, Madrazo de la Garza A, Gomez A, Muñoz O. Validation of a serologic test for the diagnosis of Helicobacter pylon infection and the immune response to urease and CagA in children. Am J Gastroenterol 1998; 93:1264-1270
24. Yamaguchi E, Itoh A, Hizawa N, Kawakami Y. The gene polymorphism of tumor necrosis factor-beta, but not that of tumor necrosis factor-alpha, is associated with the prognosis of sarcoidosis. Chest 2001; 119:753-761
25. Milner CM, Campbell RD. Polymorphic analysis of the three MHC-linked HSP70 genes. Immunogenetics 1992; 36:357-362
26. Svejgaard A, Ryder LP. HLA and disease associations: Detecting the strongest association. Tissue Antigens 1994; 43: 18-27.
27. Petrie A, Sabin C. Medical statistics at a glance. Massachusetts: Blackwell Science Ltd, 2000, 138 p.
28. Sham P. Statistics in human genetics. Arnold Applications of Statistics. New York: Oxford University Press Inc. 2001.
29. Hervada VX, Santiago PM, Vazquez FE, Castillo SC, Loyola EE, Silva ALC. Epidat 3.0 programa para análisis epidemiológico de datos tabulados. Rev. Esp. Salud Publica 2004; 78:277-280
30. Torres J, Leal-Herrera Y, Perez-Perez G, Gomez A, Camorlinga-Ponce M, CedilloRivera R, Tapia-Conyer R, Muñoz O. A community-based seroepidemiologic study of Helicobacter pylori infection in Mexico. J.infect Dis 1998; 178:1089-1094
31. Zhang J, Dou C, Song Y, Ji C, Gu S, Xie Y, Mao Y. Polymorphisms of tumor necrosis factor-alpha are associated with increased susceptibility to gastric cancer: a metaanalysis. J Hum Genet 2008; 53:479-489
32. Garza-Gonzalez E, Bosques-Padilla FJ, ElOmar E, Hold G, Tijerina-Menchaca R, Maldonado-Garza HJ, Pérez-Pérez GI. Role of polymorphic IL-IB, IL-1RN and TNF-A genes in distal gastric cancer in Mexico. Int J Cancer 2005; 114:237-241
33. Gorodezky C, Alaez C, Vázquez-García MN, de la Rosa G, Infante E, Balladares S, Toribio R, Pérez-Luque E, Muñoz L. The Genetic structure of Mexican Mestizos of different locations: tracking back their origins through MHC genes, blood group systems, and microsatellites. Hum Immunol 2001; 62:979-991
34. Torres MM, Acosta CP, Sicard DM, Groot de Restrepo H. Genetic susceptibility and risk of gastric cancer in a human population of Cauca, Colombia. Biomedica 2004; 24:153-162
35. Gyulai Z, Klausz G, Tiszai A, Lenart Z, Toth Kasa I, Lonovics J, Mandi Y. Genetic polymorphism of interleukin-8 (IL-8) is associated with Helicobacter pylori-induced duodenal ulcer. Eur Cytokine Netw 2004; 15:353-358
36. Li C, Xia B, Yang Y, Li J, Xia HH. TNF gene polymorphism and Helicobacter pylori infection in gastric carcinogenesis in Chinese population, Am J Gastroenterol 2005; 100:290-294
37. Kim N, Cho SI, Yim JY, Kim JM, Lee DH, Park JH, Kim JS, Jung HC, Song IS. The effects of genetic polymorphism of IL-1 and TNF-A on Helicobacter pylori-induced gastroduodenal diseases in Korea. Helicobacter 2006; 11:105-112 (Pubitemid 43363309)
38. Sugimoto M, Furuta T, Shirai N, Nakamura A, Xiao F, Kajimura M, Sugimura H, Hishida A. Different effects of polymorphisms of tumor necrosis factoralpha and interleukin-1 beta on development of peptic ulcer and gastric cancer. J Gastroenterol Hepatol 2007; 22:51-59
39. Gorouhi F, Islami F, Bahrami H, Kamangar F. Tumour-necrosis factor-A polymorphism and gastric cancer risk: a meta-analysis. Br J Cancer 2008; 98: 1443-1451
40. Seno H, Satoh K, Tsuji S, Shiratsuchi T, Harada Y, Hamajima N, Sugano K, Kawano S, Chiba T, Novel interleukin-4 and interleukin-1 receptor antagonist gene variations associated with non-cardia gastric cancer in Japan: comprehensive analysis of 207 polymorphisms of 11 cytokine genes. J Gastroenterol Hepatol 2007; 22:729-737
41. Curtis D, Lehman R, Zamore PD. Translational regulation in development. Cell 1995; 81:171-178
42. Canoz O, Beleni O, Patiroglu TE. General features of gastric carcinomas and comparison of HSP70 and NK cell immunoreactivity with prognostic factors. Pathol Oncol Res 2002; 8:262-269
43. Kawanishi K, Shiozaki H, Doki Y, Sakita I, Inoue M, Yano M, Tsujinaka T, Shamma A, Monden M. Prognostic significance of heat shock proteins 27 and 70 in patients with squamous cell carcinoma of the esophagus. Cancer 1999; 85:1649-1657
44. Shibata T, Arisawa T, Tahara T.Yoshioka D, Maruyama N, Fujita H, Kamiya Y, Nakamura M, Nagasaka M, Iwata M, Takahama K, Watanabe M, et al. Protective role of genetic polymorphism of heat shock protein 70-2 for gastric cancer risk. Dig Dis Sd 2009; 54:70-74
45. Suganuma M, Yamaguchi K, Ono Y, Matsumoto H, Hayashi T, Ogawa T, Imai K, Kuzuhara T, Nish.izo.no A, Fujiki H, TNF-alpha-inducing protein, a carcinogenic factor secreted from H, pylori, enters gastric cancer cells. Int J Cancer. 2008; 123:117-122
46. Targosz A, Pierzchalski P, Krawiec A, Szczyrk U, Brzozowski T, Konturek SJ, Pawlik WW. Helicobacter pylori inhibits expression of heat shock protein 70 (HSP70) in human epithelial cell line. Importance of Cag A protein. J Physiol Pharmacol 2006; 57:265-278
47. Izutani R, Katoh M, Asano S, Ohyanagi H, Hirose K. Enhanced expression of manganese superoxide dismutase mRNA and increased TNF alpha mRNA expression by gastric mucosa in gastric cancer. World J Surg 1996; 20:228-233
48. Zhang X, Chen Y, Liu Y, Zhou X, Fan D. Local cytokines profile in gastric cancer lesions. Zhonghua Zhong Liu Za Zhi 2002; 24:14-16
49. Isomoto H, Oka M, Yano Y, Kanazawa Y, Soda H, Terada R, Yasutake T, Nakayama T, Shikuwa S, Takeshima F, Udono H, Murata I, et al. Expression of heat shock protein (Hsp) 70 and Hsp 40 in gastric cancer. Cancer Lett. 2003; 198:219-228 (Pubitemid 37297795)
50. Leek RD, Landers R, Fox SB, Ng F, Harris AL, Lewis CE. Association of tumour necrosis factor alpha and its receptors with thymidine Phosphorylase expression in invasive breast carcinoma. Br J Cancer 1998; 77:2246-2251
51. Suto R, Srivastava PK. A mechanism for the specific immunogenicity of heat shock protein-chaperoned-peptides. Science 1995; 269:1585-1588
52. Asea. A, Kraeft SK, Kurt-Jones EA, Stevenson MA, Chen LB, Finberg RW, Koo GC, Calderwood SK. HSP70 stimulates cytokine production through a CD14dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 2000; 6:435-442.
53. Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, Stevenson MA, Calderwood SK. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TL.R4. J Biol Chem 2002; 277:15028-15034.
54. Jäättelä M. Overexpression of major heat shock protein HSP70 inhibits tumor necrosis factor-induced activation of phospholipase A2. J Immunol 1993; 151: 4286-4294
55. Soti C, Csermely P. Molecular chaperones in the etiologiy and therapy of cancer. Pathol Oncol Res 1998; 4:316-321
56. Chouchane L, Ahmed SB, Baccouche S, Remadi S. Polymorphism in the tumor necrosis factor-alpha promotor region and in the heat shock protein 70 genes associated with malignant tumors. Cancer 1997; 80:1489-1496
57. Mestiri S, Bouaoulna N, Ahmed SB, Khedhaler A, Belhaldj B, Couchane L. Genetic variation in the Tumor Necrosis Factor-a promoter region and in the stress protein hsp70-2: Susceptibility and prognostic implications in breast carcinoma. Cancer 2001; 91:672-678
58. Ruol A, Parenti A, Zaninotto G, Merigliano S, Costantini M, Cagol M. Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett esophagus and adenocarcinoma of the gastric cardia. Cancer 2000; 88:2520-2528
59. Torres J, Perez-Perez GI, Leai-Herrera Y, Muñoz O. Infection with CagA+ Helicobacter pylori strains as a possible predictor of risk in the development of gastric adenocarcinoma in Mexico, Int J Cancer 1998; 78:298-300.
60. Klaamas K, Held M, Wadström T, Lipping A, Kurtenkov O. IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int J Cancer 1996; 67:1-5.
61. Camorlinga-Ponce M, Flores-Luna L, Lazcano-Ponce E, Herrero R, BernaiSahagún F, Abdo-Francis JM, AguirreGarcía J, Muñoz N, Torres J. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies. Cancer Epidemiol Biomarkers Prev 2008; 17: 2498-2504
62. Correa P. Helicobacter pylori and gastric cancer: state of the art. Cancer Epidemiol Biomarkers Prev 1996; 5:477-481 (Pubitemid 26182664)